Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.

about

Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.

Item

http://www.wikidata.org/entity/Q43075638

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Evidence Based Review of Pharm ...... onstipation in Noncancer Pain.

@en

Evidence Based Review of Pharm ...... onstipation in Noncancer Pain.

@nl

type

Item

label

Evidence Based Review of Pharm ...... onstipation in Noncancer Pain.

@en

Evidence Based Review of Pharm ...... onstipation in Noncancer Pain.

@nl

prefLabel

Evidence Based Review of Pharm ...... onstipation in Noncancer Pain.

@en

Evidence Based Review of Pharm ...... onstipation in Noncancer Pain.

@nl

P1476

Evidence Based Review of Pharm ...... onstipation in Noncancer Pain.

@en

P2093

Erica A Sheridan

http://www.w3.org/2001/XMLSchema#string

Julie A Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial.

Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.

Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.

Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study.

A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.

A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.

Trends in long-term opioid therapy for chronic non-cancer pain.

Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients With Chronic Noncancer Pain: A Placebo Crossover Analysis.

A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.

A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation.

P304

1060028017739637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028017739637

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29092627

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy